BATS:ARKG
ARK Genomic Revolution ETF | |
| $ 39.87 -0.22 ( -0.55%) 04:00 PM EST | |
PE Ratio:
25.2
PB Ratio:
3.56
Volume:
3.51M
Dividend Yield %:
0
| |
| Last Holding update 2026-06-23 | 32 Stocks (4 new) |
| Value $1.23 Bil | Turnover 9 % |
Registrant: Ark ETF Trust
| |
Year: 2026
GuruFocus Rankings
Financial Strength
6 /10
Profitability Rank
3 /10
GF Value Rank
4 /10
Growth Rank
7 /10
Momentum Rank
8 /10
ARK Genomic Revolution ETF Geographic Breakdown
ARK Genomic Revolution ETF Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
ARK Genomic Revolution ETF Key Statistics
| Name | Value | ||
|---|---|---|---|
| Day's Open ($) | 39.39 | ||
| Day's Range ($) | 38.99 - 40.11 | ||
| Day's Volume | 3,513,184 | ||
| 52-Week Range ($) | 22.73 - 44.465 | ||
| Beta | 2.266 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.42 | ||
| Volatility | 34.78 | ||
| 14-Day RSI | 54.6 | ||
| 14-Day ATR ($) | 1.69202 | ||
| 20-Day SMA ($) | 40.4845 |
Fundamental Data
| Name | Value | ||
|---|---|---|---|
| Market Cap (Mil $) | 1,670.504 | ||
| Shares Outstanding (Mil) | 41.9 | ||
| PE Ratio | 25.2 | ||
| PE Ratio (10y Range) | 20.43 - 41.03 | ||
| PE Ratio (10y Median) | 28.11 | ||
| PB Ratio | 3.56 | ||
| PB Ratio (10y Range) | 1.9 - 8.1 | ||
| PB Ratio (10y Median) | 4.26 |
Dividend Data
| Name | Value | ||
|---|---|---|---|
| Dividends per Share (TTM) ($) | - | ||
| Dividend Yield % | - | ||
| Dividend Yield % (10y Range) | 0.39 - 3.23 | ||
| Dividend Yield % (10y Median) | 0.62 | ||
| Next Dividend Payment Date | |||
| Dividend Frequency | - |
ARKG ARK Genomic Revolution ETF Fundamental Charts
Historical TTM Price-to-Earnings for ARKG ARK Genomic Revolution ETF
Historical TTM Price-to-Earnings without NRI for ARKG ARK Genomic Revolution ETF
Historical Price-to-Book Ratio for ARKG ARK Genomic Revolution ETF
Historical Dividend Yields for ARKG ARK Genomic Revolution ETF
ARK Genomic Revolution ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with BATS:ARKG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BATS:ARKG is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARK Genomic Revolution ETF Top Holdings of 2026-04-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEM | Tempus AI Inc | 2,098,455 | 116,422.3 | +19.55% | 9.460 | +1.55% | 1.170 | -6.09% | -11.14% | 9,421.8 | Healthcare Providers & Services | |
TWST | Twist Bioscience Corp | 1,900,539 | 111,086.5 | -14.74% | 9.030 | -1.07% | 3.050 | +56.93% | +195.90% | 5,844.8 | Medical Diagnostics & Research | |
CRSP | CRISPR Therapeutics AG | 2,103,707 | 110,108.0 | +3.40% | 8.950 | +0.29% | 2.140 | -17.61% | -8.89% | 4,705.6 | Biotechnology | |
TXG | 10x Genomics Inc | 3,232,541 | 71,277.5 | -1.70% | 5.790 | -0.09% | 2.550 | +67.71% | +168.18% | 5,553.1 | Healthcare Providers & Services | |
BEAM | Beam Therapeutics Inc | 2,212,153 | 67,094.6 | +0.12% | 5.450 | +0.01% | 2.150 | -12.30% | -0.69% | 2,832.3 | Biotechnology | |
ABSI | Absci Corp | 11,876,202 | 59,084.1 | -1.19% | 4.800 | -0.03% | 7.620 | +131.70% | +137.68% | 1,405.2 | Biotechnology | |
NTRA | Natera Inc | 243,718 | 50,244.9 | +3.05% | 4.080 | +0.12% | 0.170 | +30.23% | +18.46% | 38,867.2 | Medical Diagnostics & Research | |
ILMN | Illumina Inc | 392,835 | 49,787.9 | -1.17% | 4.050 | -0.05% | 0.260 | +38.77% | +42.31% | 28,240.1 | Medical Diagnostics & Research | |
NTLA | Intellia Therapeutics Inc | 3,498,399 | 47,158.4 | +16.80% | 3.830 | +0.55% | 2.500 | -23.91% | +26.53% | 1,589.3 | Biotechnology | |
PSNL | Personalis Inc | 8,017,242 | 44,255.2 | -3.74% | 3.600 | -0.23% | 7.660 | +128.68% | +93.34% | 1,611.7 | Medical Diagnostics & Research |
ARK Genomic Revolution ETF's Historical Top Holdings Breakdowns
ARK Genomic Revolution ETF's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
TEM | Tempus AI Inc | 2026-04-30 | Add Add | +1.55% | 42.37 ($51.59) 59.96 | $52.47 | 1.71% | Add 19.55% | 2,098,455 | 343,105 | |
GH | Guardant Health Inc | 2026-04-30 | Reduce Reduce | -1.54% | 78.6 ($92.78) 114.9 | $155.88 | 68.01% | Reduce -25.69% | 496,000 | -171,442 | |
AMGN | Amgen Inc | 2026-04-30 | Sold Out Sold Out | -1.22% | 338.02 ($360.13) 388.16 | $366.29 | 1.71% | Sold Out | 0 | -45,055 | |
ALMR | Alamar Biosciences Inc | 2026-04-30 | New Buy New Buy | +1.21% | 22 ($24.29) 26.69 | $25.95 | 6.83% | New holding | 596,585 | 596,585 | |
TWST | Twist Bioscience Corp | 2026-04-30 | Reduce Reduce | -1.07% | 42.07 ($50.22) 63.2 | $93.86 | 86.90% | Reduce -14.74% | 1,900,539 | -328,586 | |
BNTX | BioNTech SE | 2026-04-30 | New Buy New Buy | +1.07% | 83.89 ($99.82) 111.6 | $91.48 | -8.36% | New holding | 126,929 | 126,929 | |
INCY | Incyte Corp | 2026-04-30 | Sold Out Sold Out | -1.07% | 90.3 ($97.14) 109.03 | $117.27 | 20.72% | Sold Out | 0 | -135,992 | |
WGS | GeneDx Holdings Corp | 2026-04-30 | Add Add | +1.00% | 57.09 ($75.59) 99.01 | $63.48 | -16.02% | Add 95.07% | 401,292 | 195,573 | |
VRTX | Vertex Pharmaceuticals Inc | 2026-04-30 | Sold Out Sold Out | -0.96% | 423.24 ($457.52) 499.17 | $485.65 | 6.15% | Sold Out | 0 | -25,948 | |
LLY | Eli Lilly and Co | 2026-04-30 | New Buy New Buy | +0.95% | 851.21 ($966.07) 1107.12 | $1,179.11 | 22.05% | New holding | 12,571 | 12,571 |
ARK Genomic Revolution ETF Total Holding History ($B)
ARK Genomic Revolution ETF's Asset Allocation
ARK Genomic Revolution ETF Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
ARK Genomic Revolution ETF's Hypothetical Growth since 2026-04-30
ARK Genomic Revolution ETF's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
ARK Genomic Revolution ETF's Holdings Heat Map
Size field: